Jane Street Group, LLC Agios Pharmaceuticals, Inc. Put Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$26.68 - $34.81 $1.66 Million - $2.16 Million	-62,100 Reduced 73.84%	22,000 $640,000
Q4 2021 Feb 15, 2022	SELL	$29.58 - $49.78 $144,942 - $243,922	-4,900 Reduced 5.51%	84,100 $2.76 Million
Q3 2021 Nov 16, 2021	SELL	$41.92 - $58.18 $1.93 Million - $2.68 Million	-46,000 Reduced 34.07%	89,000 $4.11 Million
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $3.4 Million - $4 Million	65,300 Added 93.69%	135,000 $7.44 Million
Q1 2021 May 18, 2021	SELL	$44.23 - $57.5 $3.35 Million - $4.35 Million	-75,700 Reduced 52.06%	69,700 $3.6 Million
Q4 2020 Feb 17, 2021	BUY	$33.21 - $46.54 $3.31 Million - $4.64 Million	99,700 Added 218.16%	145,400 $6.3 Million
Q3 2020 Nov 17, 2020	BUY	$33.87 - $55.93 $1.15 Million - $1.91 Million	34,100 Added 293.97%	45,700 $1.6 Million
Q2 2020 Aug 17, 2020	BUY	$34.45 - $53.48 $161,915 - $251,355	4,700 Added 68.12%	11,600 $620,000
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $217,488 - $371,289	6,900 New	6,900 $245,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.